A deep dive into Truist Financial's valuation suggests its current share price may not fully reflect its underlying earnings power and book value, presenting a potential opportunity for investors.
As Li Auto's stock languishes near 52-week lows, a deep dive into its valuation metrics suggests the electric vehicle maker may be oversold. With shares trading at a significant discount to intrinsic value estimates, analysts debate whether this is a moment of crisis or a potential buying window.
A hawkish Fed nominee and geopolitical tensions trigger a broad market sell-off, with one analyst forecasting an 87% collapse in Bitcoin from current levels.
Former Binance CEO Changpeng Zhao (CZ) has tempered his earlier prediction of a 2026 Bitcoin 'supercycle,' citing heightened market volatility, geopolitical tensions, and the pervasive impact of misinformation. While long-term optimism remains, the path forward appears more complex.
A recent adjustment to Dexterra Group's price target by analysts, issued without detailed rationale, has stirred debate among market watchers. The move prompts a closer look at the underlying factors that may be influencing valuation models for the facilities management and workforce accommodation provider.
While analyst price targets often paint a rosy picture, a closer look reveals a more nuanced reality. We examine one favored stock with solid fundamentals and two others where the Street's optimism may be overlooking critical risks.
In a landmark move to end regulatory ambiguity, the SEC and CFTC have formally merged their 'Project Crypto' into a single rulebook. The joint initiative aims to harmonize federal oversight of crypto markets, drawing clearer lines between securities and commodities as legislative efforts advance in Congress.
While low-volatility stocks can anchor a portfolio, investors often sacrifice growth for safety. We analyze one steady performer with durable advantages and two companies where challenges may outweigh the stability premium.
While several stocks have posted impressive short-term gains, a closer look reveals a divergence between fleeting catalysts and fundamental strength. We analyze one surging name with a solid foundation and two others where caution may be warranted.
The Austrian government has granted a two-year renewal for the Wolfsberg lithium mining license, with a final decision on production expected by end-2026 as lithium prices rebound strongly.
Singapore will establish its National Space Agency on April 1st, aiming to leverage its technological prowess to secure a strategic position in the rapidly expanding global space economy, as global investments continue to soar.
Alphabet's self-driving subsidiary Waymo is reportedly seeking a new funding round that would value the company at approximately $110 billion, drawing fresh attention to the tech giant's ambitious bets beyond its core advertising business and the evolving landscape of autonomous vehicle investment.
With its blockbuster Humira era in the rearview, AbbVie is betting big on its next-generation immunology drugs and a deep pipeline to drive growth and maintain its crown among Dividend Kings.
Silver prices have erased most of their historic 2025-2026 gains in a dramatic reversal, highlighting the profound and volatile impact of Chinese retail speculation on global commodity markets.
Takeda Pharmaceutical raises its FY2025 revenue and profit guidance following resilient nine-month results and announces U.S. availability of a new ready-to-use immunoglobulin therapy for primary immunodeficiency, fueling discussions on its growth strategy amid high debt and margin pressures.
Virgin Galactic's shares have cratered to near $3, presenting a stark dilemma for investors. While a traditional valuation model suggests a staggering 95% discount, the market's skepticism reflects deep-seated concerns over the company's path to profitability in the nascent space tourism sector.
Harmony Biosciences CFO Sandip Kapadia has liquidated his entire direct stake in the company, a move that contrasts sharply with the firm's robust financial performance and bullish $1 billion revenue target for its flagship drug WAKIX by 2026. While the sales were pre-planned, the timing fuels debate on insider confidence versus corporate optimism.
The S&P 500's 1.4% rise in January 2026 aligns with a decades-old market indicator, the 'January Barometer,' which historically signals strong full-year performance. Analysis of the past 40 years shows an 80% probability of gains through December following a positive January.
At a Singapore aviation conference, FAA Administrator Bryan Bedford publicly accepted the NTSB's findings that agency failures contributed to a mid-air collision that claimed 67 lives, vowing to implement safety reforms.
The annual Sunday Times Tax List reveals the UK's top 100 individual taxpayers paid a record £5.76bn, featuring a mix of business titans, sports stars, and entertainers, with a notable rise in contributions linked to recent fiscal policy changes.
